Evidence map›Paper›PMID 36601289›Full record

ArticleInfection prevention in practice2023

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.

Aurelien Amiot, Anne Bourrier, Jean-Marc Gornet, Olivier Dewit, Stephane Nancey, Romain Altwegg, Vered Abitbol, David Laharie, Catherine Reenaers, Charlotte Gagnière and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection prevention in practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 16 institutions in 3 countries.

Aurelien AmiotDepartment of Gastroenterology, Bicêtre Hospital, AP-HP, Paris Est Creteil University, Le Kremlin Bicêtre, France.
Anne BourrierSaint Antoine Hospital, Gastroenterology Unit, Centre de Recherche Saint-Antoine, Sorbonne Université, INSERM 75012, Assistance Publique-Hôpitaux de Paris, France.
Jean-Marc GornetDepartment of Gastroenterology, Saint Louis University Hospital, AP-HP, Paris, France.
Olivier DewitDepartment of HepatoGastroenterology, Catholic University of Leuven, University Hospital of Saint-Luc, Brussels, Belgium.
Stephane NanceyDepartment of Gastroenterology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Pierre-Benite, France.
Romain AltweggDepartment of Hepatogastroenterology, Saint-Eloi Hospital, Montpellier, France.
Vered AbitbolDepartment of Gastroenterology, Cochin University Hospital, University Paris 5 Descartes, Paris, France.
David LaharieDepartment of Hepato-Gastroenterology, University Hospital of Bordeaux, Hôpital Haut-Lévêque, Bordeaux, France.
Catherine ReenaersDepartment of Gastroenterology, University Hospital of Liège, Liège, Belgium.
Charlotte GagnièreDepartment of Gastroenterology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France.
Anthony BuissonDepartment of Hepato-Gastroenterology, University Hospital Estaing of Clermont-Ferrand, Université d'Auvergne, Clermont-Ferrand, France.
Maria NachuryDepartment of Gastroenterology, Huriez University Hospital, Université Lille Nord de France, Lille, France.
Stephanie ViennotDepartment of Gastroenterology, Besançon University Hospital, Besançon, France.
Lucine VuittonDepartment of Gastroenterology, Caen University Hospital, F-14000, Caen, France.
Carmen StefanescuDepartment of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, University Paris 7 Denis Diderot, Clichy, France.
Philippe MarteauSorbonne Université-APHP, Tenon Hospital, Paris, France.
Guillaume BouguenDepartment of Gastroenterology, Pontchaillou Hospital and Rennes University, Rennes, France.
Philippe SeksikSaint Antoine Hospital, Gastroenterology Unit, Centre de Recherche Saint-Antoine, Sorbonne Université, INSERM 75012, Assistance Publique-Hôpitaux de Paris, France.
GETAID-INFOPRO study group
Centre Hospitalier Universitaire de Besançon · FRInserm · FRAssistance Publique – Hôpitaux de Paris · FRCatholic University of America · USCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Rennes · FRDélégation Paris 5 · FRHôpital Saint Eloi · FRSaint Louis University Hospital · USSorbonne Université · FRUniversité Claude Bernard Lyon 1 · FRUniversité Clermont Auvergne · FRUniversité Paris Cité · FRUniversité Paris-Est Créteil · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. Aim: To assess the risk of COVID-19 in healthcare workers with IBD. Methods: A case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak. Results: In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2 Conclusion: Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.

Indexed as

COVID-19, Novel coronavirus diseaseCrohn's diseaseCRP, C-reactive proteinHealthcare workerIBD, inflammatory bowel diseaseInflammatory bowel diseaseSARS-CoV-2SARS-CoV-2, severe acute respiratory syndrome coronavirus 2TNF, tumor necrosis factor-alphaUC, ulcerative colitisUlcerative colitis

Identifiers

PMID36601289
PMCPMC9800326
OpenAlexW4313319784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.